Holds one active US DMF for ambrisentan, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Holds one active US DMF for ambrisentan, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds one active US DMF for ambrisentan, filing since 2015. Its 2023 FDA inspection closed as VAI.
Holds one active US DMF for ambrisentan, filing since 2010. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for ambrisentan, filing since 2016. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for ambrisentan, filing since 2014. Its 2018 FDA inspection closed as VAI.
Holds one active US DMF for ambrisentan, filing since 2016.
Holds one active US DMF for ambrisentan, filing since 2013. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for ambrisentan and what filings they hold.
Chat with Fred, your AI analyst